Literature DB >> 7969118

Identification and characterization of a novel GGA/C-binding protein, GBP-i, that is rapidly inducible by cytokines.

G V Raj1, K Khalili.   

Abstract

Immunosuppressive states with accompanying alterations in cytokine profiles have been postulated to play a vital role in the reactivation of viruses from latency. Cytokines regulate gene expression by activating transcription factors via well-characterized signal transduction pathways. In this study, we report the identification of a novel inducible protein, GBP-i, that binds to a double-stranded GGA/C-rich region of the transcriptional control region of the human papovavirus JC virus (JCV), specifically within the origin of viral DNA replication. GBP-i is distinct from previously characterized GC-box-binding proteins with respect to both its sequence specificity and its electrophoretic mobility on native and denaturing gels. GBP-i responds within 90 min to phorbol myristate acetate stimulation; however, unlike typical phorbol myristate acetate-inducible factors, this rapid induction is regulated primarily at the transcriptional level. Further, the induction of GBP-i appears to be widespread and mediated by many inflammatory cytokines, including interleukin-1 beta, tumor necrosis factor alpha, gamma interferon, and transforming growth factor beta. Interestingly, the induced protein acts as a transcriptional repressor in its native context in the JCVL promoter. However, when its binding sequence is transposed to a heterologous promoter, GBP-i appears to function as a transcriptional activator. The data presented here suggest a role for GBP-i in cytokine-mediated induction of viral and cellular genes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7969118      PMCID: PMC359317          DOI: 10.1128/mcb.14.12.7770-7781.1994

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  51 in total

1.  Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor.

Authors:  C Schindler; K Shuai; V R Prezioso; J E Darnell
Journal:  Science       Date:  1992-08-07       Impact factor: 47.728

2.  Regulation of the human neurotropic virus promoter by JCV-T antigen and HIV-1 tat protein.

Authors:  M Chowdhury; J P Taylor; H Tada; J Rappaport; F Wong-Staal; S Amini; K Khalili
Journal:  Oncogene       Date:  1990-12       Impact factor: 9.867

3.  Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells.

Authors:  H Tada; J Rappaport; M Lashgari; S Amini; F Wong-Staal; K Khalili
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

4.  AIDS-associated progressive multifocal leukoencephalopathy (PML): comparison to non-AIDS PML with in situ hybridization and immunohistochemistry.

Authors:  A J Aksamit; H E Gendelman; J M Orenstein; G H Pezeshkpour
Journal:  Neurology       Date:  1990-07       Impact factor: 9.910

5.  Severe encephalitis resulting from coinfections with HIV and JC virus.

Authors:  R Vazeux; M Cumont; P M Girard; X Nassif; P Trotot; C Marche; L Matthiessen; C Vedrenne; J Mikol; D Henin
Journal:  Neurology       Date:  1990-06       Impact factor: 9.910

6.  Molecular cloning and characterization of a human DNA binding factor that represses transcription.

Authors:  R Kageyama; I Pastan
Journal:  Cell       Date:  1989-12-01       Impact factor: 41.582

7.  Persistent human immunodeficiency virus type 1 infection in human fetal glial cells reactivated by T-cell factor(s) or by the cytokines tumor necrosis factor alpha and interleukin-1 beta.

Authors:  C Tornatore; A Nath; K Amemiya; E O Major
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

8.  A 65-kappaD subunit of active NF-kappaB is required for inhibition of NF-kappaB by I kappaB.

Authors:  P A Baeuerle; D Baltimore
Journal:  Genes Dev       Date:  1989-11       Impact factor: 11.361

9.  Detection of JC virus DNA in peripheral lymphocytes from patients with and without progressive multifocal leukoencephalopathy.

Authors:  C Tornatore; J R Berger; S A Houff; B Curfman; K Meyers; D Winfield; E O Major
Journal:  Ann Neurol       Date:  1992-04       Impact factor: 10.422

10.  Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid.

Authors:  P Gallo; K Frei; C Rordorf; J Lazdins; B Tavolato; A Fontana
Journal:  J Neuroimmunol       Date:  1989-07       Impact factor: 3.478

View more
  19 in total

Review 1.  Epidemiological evidence and molecular basis of interactions between HIV and JC virus.

Authors:  J R Berger; A Chauhan; D Galey; A Nath
Journal:  J Neurovirol       Date:  2001-08       Impact factor: 2.643

2.  Transforming growth factor beta-induced reactivation of Epstein-Barr virus involves multiple Smad-binding elements cooperatively activating expression of the latent-lytic switch BZLF1 gene.

Authors:  Tawin Iempridee; Shreyasi Das; Iris Xu; Janet E Mertz
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

3.  Interaction of JC virus agno protein with T antigen modulates transcription and replication of the viral genome in glial cells.

Authors:  M Safak; R Barrucco; A Darbinyan; Y Okada; K Nagashima; K Khalili
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

4.  Functional interaction between JC virus late regulatory agnoprotein and cellular Y-box binding transcription factor, YB-1.

Authors:  Mahmut Safak; Beata Sadowska; Robert Barrucco; Kamel Khalili
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

5.  Advances in the biology of JC virus and induction of progressive multifocal leukoencephalopathy.

Authors:  Pankaj Seth; Frank Diaz; Eugene O Major
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

Review 6.  An overview: Human polyomavirus JC virus and its associated disorders.

Authors:  Mahmut Safak; Kamel Khalili
Journal:  J Neurovirol       Date:  2003       Impact factor: 2.643

7.  Transcription of the JC virus archetype late genome: importance of the kappa B and the 23-base-pair motifs in late promoter activity in glial cells.

Authors:  R P Mayreddy; M Safak; M Razmara; P Zoltick; K Khalili
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

8.  Early growth response-1 protein is induced by JC virus infection and binds and regulates the JC virus promoter.

Authors:  Luca Romagnoli; Ilker K Sariyer; Jacqueline Tung; Mariha Feliciano; Bassel E Sawaya; Luis Del Valle; Pasquale Ferrante; Kamel Khalili; Mahmut Safak; Martyn K White
Journal:  Virology       Date:  2008-03-18       Impact factor: 3.616

9.  Interferon beta1-a and selective anti-5HT(2a) receptor antagonists inhibit infection of human glial cells by JC virus.

Authors:  B A O'Hara; W J Atwood
Journal:  Virus Res       Date:  2008-03       Impact factor: 3.303

10.  Members of the AP-1 family, c-Jun and c-Fos, functionally interact with JC virus early regulatory protein large T antigen.

Authors:  Joanne Kim; Stefanie Woolridge; Renato Biffi; Elisa Borghi; Adam Lassak; Pasquale Ferrante; Shohreh Amini; Kamel Khalili; Mahmut Safak
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.